ADENOSINE

Adenosine Adverse Events Reported to the FDA Over Time

How are Adenosine adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Adenosine, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Adenosine is flagged as the suspect drug causing the adverse event.

Most Common Adenosine Adverse Events Reported to the FDA

What are the most common Adenosine adverse events reported to the FDA?

Drug Interaction	29 (2.77%)
Bronchospasm	26 (2.49%)
Dyspnoea	26 (2.49%)
Pleural Effusion	24 (2.29%)
Supraventricular Tachycardia	24 (2.29%)
Myositis	23 (2.2%)
Pericardial Effusion	22 (2.1%)
Pulmonary Embolism	22 (2.1%)
Liver Function Test Abnormal	21 (2.01%)
Cardiac Arrest	20 (1.91%)
Asthenia	18 (1.72%)
	Show More
Pneumonia	17 (1.63%)
Respiratory Arrest	16 (1.53%)
Infusion Related Reaction	15 (1.43%)
Myalgia	14 (1.34%)
Myopathy	14 (1.34%)
Alanine Aminotransferase Increased	13 (1.24%)
Bradycardia	13 (1.24%)
Aspartate Aminotransferase Increase...	12 (1.15%)
Hypokinesia	12 (1.15%)
Infection	12 (1.15%)
Loss Of Consciousness	12 (1.15%)
Atrial Fibrillation	11 (1.05%)
Cardio-respiratory Arrest	11 (1.05%)
Drug Ineffective	11 (1.05%)
Arteriospasm Coronary	10 (.96%)
Blood Creatine Phosphokinase Increa...	10 (.96%)
Hypokalaemia	10 (.96%)
Medication Error	10 (.96%)
Respiratory Distress	10 (.96%)
Headache	9 (.86%)
Hypotension	9 (.86%)
Nausea	9 (.86%)
Tachycardia	9 (.86%)
Chest Pain	8 (.76%)
Flushing	8 (.76%)
Ventricular Tachycardia	8 (.76%)
Dizziness	7 (.67%)
Pain	7 (.67%)
Renal Failure	7 (.67%)
Convulsion	6 (.57%)
Heart Rate Increased	6 (.57%)
Hypoxia	6 (.57%)
Metabolic Acidosis	6 (.57%)
Oxygen Saturation Decreased	6 (.57%)
Procedural Complication	6 (.57%)
Wheezing	6 (.57%)
Apnoea	5 (.48%)
Atrioventricular Block	5 (.48%)
Atrioventricular Block Complete	5 (.48%)
Chest Discomfort	5 (.48%)
Electrocardiogram St Segment Elevat...	5 (.48%)
Facial Pain	5 (.48%)
Tachypnoea	5 (.48%)
Abdominal Pain	4 (.38%)
Anaphylactic Reaction	4 (.38%)
Breath Sounds Abnormal	4 (.38%)
Circumstance Or Information Capable...	4 (.38%)
Condition Aggravated	4 (.38%)
Device Occlusion	4 (.38%)
Dilatation Atrial	4 (.38%)
Electrocardiogram St Segment Depres...	4 (.38%)
Fatigue	4 (.38%)
Haemoglobin Decreased	4 (.38%)
Hepatitis Fulminant	4 (.38%)
Left Ventricular Dysfunction	4 (.38%)
Livedo Reticularis	4 (.38%)
Neurological Symptom	4 (.38%)
Respiratory Gas Exchange Disorder	4 (.38%)
Sinus Arrest	4 (.38%)
Sinus Bradycardia	4 (.38%)
Vision Blurred	4 (.38%)
Acute Respiratory Failure	3 (.29%)
Atrial Flutter	3 (.29%)
Basal Cell Carcinoma	3 (.29%)
Blood Pressure Decreased	3 (.29%)
Blood Pressure Systolic Increased	3 (.29%)
Circulatory Collapse	3 (.29%)
Confusional State	3 (.29%)
Coronary Artery Stenosis	3 (.29%)
Cyanosis	3 (.29%)
Depressed Level Of Consciousness	3 (.29%)
Device Failure	3 (.29%)
Drug Hypersensitivity	3 (.29%)
Ejection Fraction Decreased	3 (.29%)
Extravasation	3 (.29%)
Feeling Abnormal	3 (.29%)
Hyperhidrosis	3 (.29%)
Hyperkalaemia	3 (.29%)
Hypersensitivity	3 (.29%)
Hypertension	3 (.29%)
Incorrect Route Of Drug Administrat...	3 (.29%)
Movement Disorder	3 (.29%)
Pain In Extremity	3 (.29%)
Pallor	3 (.29%)
Post Procedural Complication	3 (.29%)
Pulmonary Oedema	3 (.29%)
Respiratory Depression	3 (.29%)
Rhabdomyolysis	3 (.29%)
Syringe Issue	3 (.29%)
Urticaria	3 (.29%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Adenosine, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Adenosine is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Adenosine

What are the most common Adenosine adverse events reported to the FDA?

Cardiac Arrhythmias	136 (13%)
Respiratory	89 (8.51%)
Muscle	58 (5.54%)
Hepatobiliary	46 (4.4%)
Therapeutic And Nontherapeutic Effe...	42 (4.02%)
Neurological	36 (3.44%)
Bronchial Disorders	35 (3.35%)
Infections - Pathogen Unspecified	35 (3.35%)
Cardiac And Vascular Investigations	34 (3.25%)
Procedural And Device Related Injur...	26 (2.49%)
Coronary Artery	24 (2.29%)
	Show More
Pleural	24 (2.29%)
Medication Errors	22 (2.1%)
Pericardial	22 (2.1%)
Pulmonary Vascular	22 (2.1%)
Movement Disorders	18 (1.72%)
Gastrointestinal Signs	17 (1.63%)
Administration Site Reactions	15 (1.43%)
Electrolyte And Fluid Balance Condi...	13 (1.24%)
Enzyme	13 (1.24%)
Myocardial	13 (1.24%)
Vascular	13 (1.24%)
Decreased And Nonspecific Blood Pre...	12 (1.15%)
Renal Disorders	12 (1.15%)
Allergic Conditions	10 (.96%)
Headaches	9 (.86%)
Hepatic And Hepatobiliary	8 (.76%)
Metabolic, Nutritional And Blood Ga...	8 (.76%)
Cardiac Disorder Signs	7 (.67%)
Hematology Investigations	7 (.67%)
Acid-base	6 (.57%)
Musculoskeletal And Connective Tiss...	6 (.57%)
Physical Examination Topics	6 (.57%)
Seizures	6 (.57%)
Viral Infectious	6 (.57%)
Skin Appendage Conditions	5 (.48%)
Vision	5 (.48%)
Bacterial Infectious	4 (.38%)
Deliria	4 (.38%)
Heart Failures	4 (.38%)
Skin Vascular Abnormalities	4 (.38%)
Urinary Tract Signs	4 (.38%)
Angiedema And Urticaria	3 (.29%)
Anxiety Disorders	3 (.29%)
Bone And Joint Injuries	3 (.29%)
Bone Disorders	3 (.29%)
Chemical Injury And Poisoning	3 (.29%)
Hematological And Lymphoid Tissue T...	3 (.29%)
Increased Intracranial Pressure And...	3 (.29%)
Joint	3 (.29%)
Lower Respiratory Tract Disorders	3 (.29%)
Mental Impairment	3 (.29%)
Skin Neoplasms Malignant And Unspec...	3 (.29%)
Upper Respiratory Tract Disorders	3 (.29%)
Vascular Hypertensive	3 (.29%)
Cardiac Therapeutic Procedures	2 (.19%)
Dental And Gingival Conditions	2 (.19%)
Encephalopathies	2 (.19%)
Epidermal And Dermal Conditions	2 (.19%)
Eye	2 (.19%)
Injuries	2 (.19%)
Maternal Complications Of Labour An...	2 (.19%)
Product Quality Issues	2 (.19%)
Renal And Urinary Tract Investigati...	2 (.19%)
Tongue Conditions	2 (.19%)
Abdominal Hernias And Other Abdomin...	1 (.1%)
Abortions And Stillbirth	1 (.1%)
Age Related Factors	1 (.1%)
Body Temperature Conditions	1 (.1%)
Breast	1 (.1%)
Central Nervous System Vascular	1 (.1%)
Changes In Physical Activity	1 (.1%)
Communication Disorders	1 (.1%)
Depressed Mood Disorders	1 (.1%)
Eating Disorders	1 (.1%)
Endocrine Neoplasms Malignant And U...	1 (.1%)
Fetal Complications	1 (.1%)
Fractures	1 (.1%)
Gastrointestinal Motility And Defec...	1 (.1%)
Immunodeficiency Syndromes	1 (.1%)
Investigations, Imaging And Histopa...	1 (.1%)
Mood Disorders	1 (.1%)
Neonatal And Perinatal Conditions	1 (.1%)
Nervous System Neoplasms Malignant ...	1 (.1%)
Neuromuscular	1 (.1%)
Ocular Sensory Symptoms	1 (.1%)
Parathyroid Gland	1 (.1%)
Protozoal Infectious	1 (.1%)
Psychiatric	1 (.1%)
Purine And Pyrimidine Metabolism	1 (.1%)
Sleep Disorders	1 (.1%)
Therapeutic Procedures And Supporti...	1 (.1%)
Uterine, Pelvic And Broad Ligament	1 (.1%)
Vitamin Related	1 (.1%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Adenosine, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Adenosine is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.